Apoptosis and oxidative stress as relevant mechanisms of antitumor activity and genotoxicity of ZnO-NPs alone and in combination with N-acetyl cysteine in tumor-bearing mice

References

• Laurenti M, Cauda V. ZnO nanostructures for tissue engineering applications. Nanomaterials (Basel). 2017;7:11. doi:10.3390/nano7120458
   PubMedGoogle Scholar
• Saptarshi SR, Feltis BN, Wright PF, Lopata AL. Investigating the immunomodulatory nature of zinc oxide nanoparticles at sub-cytotoxic levels in vitro and after intranasal instillation in vivo. J Nanobiotechnology. 2015;13:6. doi:10.1186/s12951-015-0067-725645871
   PubMed Web of Science ®Google Scholar
• Kalpana V, Devi Rajeswari V. A review on green synthesis, biomedical applications, and toxicity studies of ZnO NPs. Bioinorg Chem Appl. 2018;2018:3569758.
   Web of Science ®Google Scholar
• Rokbani H, Daigle F, Ajji A. Combined Effect Of Ultrasound Stimulations And Autoclaving On The Enhancement Of Antibacterial Activity Of ZnO and SiO(2)/ZnO Nanoparticles. Nanomaterials (Basel). 2018;8:3. doi:10.3390/nano8030129
   Google Scholar
• Youssef AM, El-Nahrawy AM, Abou Hammad AB. Sol-gel synthesis and characterizations of hybrid chitosan-PEG/calcium silicate nanocomposite modified with ZnO-NPs and (E102) for optical and antibacterial applications. Int J Biol Macromol. 2017;97:561–567. doi:10.1016/j.ijbiomac.2017.01.05928108409
   PubMed Web of Science ®Google Scholar
• Hassan HFH, Mansour AM, Abo‐Youssef AMH, Elsadek BE, Messiha BAS. Zinc oxide nanoparticles as a novel anticancer approach; in vitro and in vivo evidence. Clin Exp Pharmacol Physiol. 2017;44(2):235–243. doi:10.1111/1440-1681.1268127718258
   PubMedGoogle Scholar
• Palanikumar L, Ramasamy S, Balachandran C. Antibacterial and cytotoxic response of nano zinc oxide in gram negative bacteria and colo 320 human adenocarcinoma cancer cells. Curr Nanosci. 2013;9(4):469–478. doi:10.2174/1573413711309040009
   Web of Science ®Google Scholar
• Namvar F, Rahman HS, Mohamad R, et al. Cytotoxic effects of biosynthesized zinc oxide nanoparticles on murine cell lines. Evid Based Complement Alternat Med. 2015;2015:593014.
   Web of Science ®Google Scholar
• Wahab R, Siddiqui MA, Saquib Q, et al. ZnO nanoparticles induced oxidative stress and apoptosis in HepG2 and MCF-7 cancer cells and their antibacterial activity. Colloids Surf B Biointerfaces. 2014;117:267–276. doi:10.1016/j.colsurfb.2014.02.03824657613
   PubMed Web of Science ®Google Scholar
• Wahab R, Kaushik NK, Verma AK, et al. Fabrication and growth mechanism of ZnO nanostructures and their cytotoxic effect on human brain tumor U87, cervical cancer HeLa, and normal HEK cells. J Biol Inorg Chem. 2011;16(3):431–442. doi:10.1007/s00775-010-0740-021140179
   PubMedGoogle Scholar
• Selvakumari D, Deepa R, Mahalakshmi V, Subhashini P, Lakshminarayan N. Anti cancer activity of ZnO nanoparticles on MCF7 (breast cancer cell) and A549 (lung cancer cell). Asian Res Pub Net J Eng Appl Sci. 2015;10:5418–5421.
   Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–674. doi:10.1016/j.cell.2011.02.01321376230
   PubMed Web of Science ®Google Scholar
• Sherr CJ. Principles of tumor suppression. Cell. 2004;116(2):235–246.14744434
   PubMed Web of Science ®Google Scholar
• Ahamed M, Karns M, Goodson M, et al. DNA damage response to different surface chemistry of silver nanoparticles in mammalian cells. Toxicol Appl Pharmacol. 2008;233(3):404–410. doi:10.1016/j.taap.2008.09.01518930072
   PubMed Web of Science ®Google Scholar
• Farnebo M, Bykov VJ, Wiman KG. The p53 tumor suppressor: a master regulator of diverse cellular processes and therapeutic target in cancer. Biochem Biophys Res Commun. 2010;396(1):85–89. doi:10.1016/j.bbrc.2010.02.15220494116
   PubMed Web of Science ®Google Scholar
• Chougule M, Patel AR, Sachdeva P, Jackson T, Singh M. Anticancer activity of Noscapine, an opioid alkaloid in combination with Cisplatin in human non-small cell lung cancer. Lung Cancer. 2011;71(3):271–282. doi:10.1016/j.lungcan.2010.06.00220674069
   PubMed Web of Science ®Google Scholar
• Deng X, Gao F, Flagg T, Anderson J, May WS. Bcl2’s flexible loop domain regulates p53 binding and survival. Mol Cell Biol. 2006;26(12):4421–4434. doi:10.1128/MCB.01647-0516738310
   PubMed Web of Science ®Google Scholar
• Landsiedel R, Ma-Hock L, Van Ravenzwaay B, et al. Gene toxicity studies on titanium dioxide and zinc oxide nanomaterials used for UV-protection in cosmetic formulations. Nanotoxicology. 2010;4(4):364–381. doi:10.3109/17435390.2010.50669420925445
   PubMed Web of Science ®Google Scholar
• Li C-H, Shen -C-C, Cheng Y-W, et al. Organ biodistribution, clearance, and genotoxicity of orally administered zinc oxide nanoparticles in mice. Nanotoxicology. 2012;6(7):746–756. doi:10.3109/17435390.2011.62071721950449
   PubMed Web of Science ®Google Scholar
• Wang B, Feng W, Wang M, et al. Acute toxicological impact of nano-and submicro-scaled zinc oxide powder on healthy adult mice. J Nanopart Res. 2008;10(2):263–276. doi:10.1007/s11051-007-9245-3
   Web of Science ®Google Scholar
• Surekha P, Kishore AS, Srinivas A, et al. Repeated dose dermal toxicity study of nano zinc oxide with Sprague-Dawley rats. Cutan Ocul Toxicol. 2012;31(1):26–32. doi:10.3109/15569527.2011.59575021830917
   PubMed Web of Science ®Google Scholar
• Millea PJ. N-acetylcysteine: multiple clinical applications. Am Fam Physician. 2009;80:3.
   Web of Science ®Google Scholar
• Agarwal A, Munoz-Nájar U, Klueh U, Shih S-C, Claffey KP. N-acetyl-cysteine promotes angiostatin production and vascular collapse in an orthotopic model of breast cancer. Am J Pathol. 2004;164(5):1683–1696. doi:10.1016/S0002-9440(10)63727-315111315
   PubMedGoogle Scholar
• Albini A, Morini M, D’Agostini F, et al. Inhibition of angiogenesis-driven Kaposi’s sarcoma tumor growth in nude mice by oral N-acetylcysteine. Cancer Res. 2001;61(22):8171–8178.11719447
   PubMed Web of Science ®Google Scholar
• Spagnuolo G, D’Antò V, Cosentino C, Schmalz G, Schweikl H, Rengo S. Effect of N-acetyl-L-cysteine on ROS production and cell death caused by HEMA in human primary gingival fibroblasts. Biomaterials. 2006;27(9):1803–1809. doi:10.1016/j.biomaterials.2005.10.02216289659
   PubMedGoogle Scholar
• Fu A-L, Dong Z-H, Sun M-J. Protective effect of N-acetyl-L-cysteine on amyloid β-peptide-induced learning and memory deficits in mice. Brain Res. 2006;1109(1):201–206. doi:10.1016/j.brainres.2006.06.04216872586
   PubMedGoogle Scholar
• Fukami G, Hashimoto K, Koike K, Okamura N, Shimizu E, Iyo M. Effect of antioxidant N-acetyl-L-cysteine on behavioral changes and neurotoxicity in rats after administration of methamphetamine. Brain Res. 2004;1016(1):90–95. doi:10.1016/j.brainres.2004.04.07215234256
   PubMed Web of Science ®Google Scholar
• Kim JH, Jeong MS, Kim DY, Her S, Wie MB. Zinc oxide nanoparticles induce lipoxygenase-mediated apoptosis and necrosis in human neuroblastoma SH-SY5Y cells. Neurochem Int. 2015;90:204–214. doi:10.1016/j.neuint.2015.09.00226364578
   PubMed Web of Science ®Google Scholar
• Albini A, D’Agostini F, Giunciuglio D, Paglieri I, Balansky R, De Flora S. Inhibition of invasion, gelatinase activity, tumor take and metastasis of malignant cells by N-acetylcysteine. Int J Cancer. 1995;61(1):121–129.7705924
   PubMed Web of Science ®Google Scholar
• Singh R, Shah R, Turner C, Regueira O, Vasylyeva TL. N-acetylcysteine renoprotection in methotrexate induced nephrotoxicity and its effects on B-cell lymphoma. Indian J Med Paediatr Oncol. 2015;36(4):243–248. doi:10.4103/0971-5851.17154526811594
   PubMedGoogle Scholar
• Kozak YS, PanchuK R, Skorokhyd N, Lehka L, StoIka R. Impact of N-acetylcysteine on antitumor activity of doxorubIcin and landomycin in NK/ly lymphoma-bearing mIce. Ukrainian Biochem J. 2018;90(2):46–54. doi:10.15407/ubj90.02.046
   Google Scholar
• Nargi JL, Ratan RR, Griffin D E. p53-independent inhibition of proliferation and p21(WAF1/Cip1)-modulated induction of cell death by the antioxidants N-acetylcysteine and vitamin E. Neoplasia. 1999;1(6):544–556.10935502
   PubMedGoogle Scholar
• Kawakami S, Kageyama Y, Fujii Y, Kihara K, Oshima H. Inhibitory effect of N-acetylcysteine on invasion and MMP-9 production of T24 human bladder cancer cells. Anticancer Res. 2001;21(1a):213–219.11299737
   PubMed Web of Science ®Google Scholar
• Supabphol A, Muangman V, Chavasiri W, Supabphol R, Gritsanapan W. N-acetylcysteine inhibits proliferation, adhesion, migration and invasion of human bladder cancer cells. J Med Assoc Thai. 2009;92(9):1171–1177.19772176
   PubMedGoogle Scholar
• Lee YJ, Lee DM, Lee CH, et al. Suppression of human prostate cancer PC-3 cell growth by N-acetylcysteine involves over-expression of Cyr61. Toxicol In Vitro. 2011;25(1):199–205. doi:10.1016/j.tiv.2010.10.02021055460
   PubMedGoogle Scholar
• Lee MF, Chan CY, Hung HC, Chou IT, Yee AS, Huang CY. N-acetylcysteine (NAC) inhibits cell growth by mediating the EGFR/Akt/HMG box-containing protein 1 (HBP1) signaling pathway in invasive oral cancer. Oral Oncol. 2013;49(2):129–135. doi:10.1016/j.oraloncology.2012.08.00322944050
   PubMedGoogle Scholar
• Hann SS, Zheng F, Zhao S. Targeting 3-phosphoinositide-dependent protein kinase 1 by N-acetyl-cysteine through activation of peroxisome proliferators activated receptor alpha in human lung cancer cells, the role of p53 and p65. J Exp Clin Cancer Res. 2013;32:43. doi:10.1186/1756-9966-32-4323867003
   PubMedGoogle Scholar
• Muldoon LL, Wu YJ, Pagel MA, Neuwelt EA. N-acetylcysteine chemoprotection without decreased cisplatin antitumor efficacy in pediatric tumor models. J Neurooncol. 2015;121(3):433–440. doi:10.1007/s11060-014-1657-125411097
   PubMed Web of Science ®Google Scholar
• Sharma R. Kinetic measurements from in situ TEM observations. Microsc Res Tech. 2009;72(3):144–152. doi:10.1002/jemt.2066719130611
   PubMedGoogle Scholar
• Tice RR, Shelby MD. International workshop on standardisation of genotoxicity test procedures. Report of in vivo subgroup. Mutat Res. 1994;312(3):287–292.7514740
   PubMedGoogle Scholar
• Sanceau J, Poupon MF, Delattre O, Sastre-Garau X, Wietzerbin J. Strong inhibition of Ewing tumor xenograft growth by combination of human interferon-alpha or interferon-beta with ifosfamide. Oncogene. 2002;21(50):7700–7709. doi:10.1038/sj.onc.120588112400012
   PubMed Web of Science ®Google Scholar
• Mayer AG, Tortugas T. Florida, as a station for research in biology. Science. 1903;17(422):190–192. doi:10.1126/science.17.422.19017818040
   PubMedGoogle Scholar
• Habig WH, Pabst MJ, Jakoby WB. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem. 1974;249(22):7130–7139.4436300
   PubMed Web of Science ®Google Scholar
• Aebi H. Catalase in vitro. Methods Enzymol. 1984;105:121–126.6727660
   PubMed Web of Science ®Google Scholar
• Tice RR, Agurell E, Anderson D, et al. Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen. 2000;35(3):206–221.10737956
   PubMed Web of Science ®Google Scholar
• Krishna PG, Ananthaswamy PP, Yadavalli T, Mutta NB, Sannaiah A, Shivanna Y. ZnO nanopellets have selective anticancer activity. Mater Sci Eng C. 2016;62:919–926. doi:10.1016/j.msec.2016.02.039
   PubMed Web of Science ®Google Scholar
• Degen A, Kosec M. Effect of pH and impurities on the surface charge of zinc oxide in aqueous solution. J Eur Ceram Soc. 2000;20(6):667–673. doi:10.1016/S0955-2219(99)00203-4
   Web of Science ®Google Scholar
• Rasmussen JW, Martinez E, Louka P, Wingett DG. Zinc oxide nanoparticles for selective destruction of tumor cells and potential for drug delivery applications. Expert Opin Drug Deliv. 2010;7(9):1063–1077. doi:10.1517/17425247.2010.50256020716019
   PubMed Web of Science ®Google Scholar
• Papo N, Shahar M, Eisenbach L, Shai Y. A novel lytic peptide composed of DL-amino acids selectively kills cancer cells in culture and in mice. J Biol Chem. 2003;278(23):21018–21023. doi:10.1074/jbc.M21120420012646578
   PubMed Web of Science ®Google Scholar
• Peetla C, Vijayaraghavalu S, Labhasetwar V. Biophysics of cell membrane lipids in cancer drug resistance: implications for drug transport and drug delivery with nanoparticles. Adv Drug Deliv Rev. 2013;65(13–14):1686–1698. doi:10.1016/j.addr.2013.09.00424055719
   PubMed Web of Science ®Google Scholar
• Moos PJ, Chung K, Woessner D, Honeggar M, Cutler NS, Veranth JM. ZnO particulate matter requires cell contact for toxicity in human colon cancer cells. Chem Res Toxicol. 2010;23(4):733–739. doi:10.1021/tx900203v20155942
   PubMed Web of Science ®Google Scholar
• Bisht G, Rayamajhi S. ZnO nanoparticles: a promising anticancer agent. Nanobiomed. 2016;3(Godište 2016):3–9. doi:10.5772/63437
   PubMedGoogle Scholar
• Carmody RJ, Cotter TG. Signalling apoptosis: a radical approach. Redox Rep. 2001;6(2):77–90. doi:10.1179/13510000110153608511450987
   PubMed Web of Science ®Google Scholar
• Guan R, Kang T, Lu F, Zhang Z, Shen H, Liu M. Cytotoxicity, oxidative stress, and genotoxicity in human hepatocyte and embryonic kidney cells exposed to ZnO nanoparticles. Nanoscale Res Lett. 2012;7(1):602. doi:10.1186/1556-276X-7-60223110934
   PubMedGoogle Scholar
• Zijno A, De Angelis I, De Berardis B, et al. Different mechanisms are involved in oxidative DNA damage and genotoxicity induction by ZnO and TiO2 nanoparticles in human colon carcinoma cells. Toxicol In Vitro. 2015;29(7):1503–1512. doi:10.1016/j.tiv.2015.06.00926079941
   PubMed Web of Science ®Google Scholar
• Pryor WA. Cancer and free radicals. Basic Life Sci. 1986;39:45–59.3767848
   PubMedGoogle Scholar
• Kang DH. Oxidative stress, DNA damage, and breast cancer. AACN Clin Issues. 2002;13(4):540–549.12473916
   PubMedGoogle Scholar
• Sharma V, Anderson D, Dhawan A. Zinc oxide nanoparticles induce oxidative stress and genotoxicity in human liver cells (HepG2). J Biomed Nanotechnol. 2011;7(1):98–99.21485822
   PubMed Web of Science ®Google Scholar
• Hackenberg S, Scherzed A, Technau A, et al. Cytotoxic, genotoxic and pro-inflammatory effects of zinc oxide nanoparticles in human nasal mucosa cells in vitro. Toxicol In Vitro. 2011;25(3):657–663. doi:10.1016/j.tiv.2011.01.00321232592
   PubMed Web of Science ®Google Scholar
• Sharma V, Anderson D, Dhawan A. Zinc oxide nanoparticles induce oxidative DNA damage and ROS-triggered mitochondria mediated apoptosis in human liver cells (HepG2). Apoptosis. 2012;17(8):852–870. doi:10.1007/s10495-012-0705-622395444
   PubMed Web of Science ®Google Scholar
• Pandurangan M, Enkhtaivan G, Kim DH. Anticancer studies of synthesized ZnO nanoparticles against human cervical carcinoma cells. J Photochem Photobiol B. 2016;158:206–211. doi:10.1016/j.jphotobiol.2016.03.00226985734
   PubMed Web of Science ®Google Scholar
• Bai Aswathanarayan J, Rai Vittal R, Muddegowda U. Anticancer activity of metal nanoparticles and their peptide conjugates against human colon adenorectal carcinoma cells. Artif Cells Nanomed Biotechnol. 2018;46(7):1444–1451. doi:10.1080/21691401.2017.137365528884587
   PubMed Web of Science ®Google Scholar
• Gao F, Ma N, Zhou H, et al. Zinc oxide nanoparticles-induced epigenetic change and G2/M arrest are associated with apoptosis in human epidermal keratinocytes. Int J Nanomedicine. 2016;11:3859–3874. doi:10.2147/IJN.S10702127570453
   PubMed Web of Science ®Google Scholar
• Boroumand Moghaddam A, Moniri M, Azizi S, et al. Eco-friendly formulated zinc oxide nanoparticles: induction of cell cycle arrest and apoptosis in the MCF-7 cancer cell line. Genes (Basel). 2017;8:10. doi:10.3390/genes8100281
   Web of Science ®Google Scholar
• Rajeshkumar S, Kumar SV, Ramaiah A, Agarwal H, Lakshmi T, Roopan SM. Biosynthesis of zinc oxide nanoparticles usingMangifera indica leaves and evaluation of their antioxidant and cytotoxic properties in lung cancer (A549) cells. Enzyme Microb Technol. 2018;117:91–95. doi:10.1016/j.enzmictec.2018.06.00930037558
   PubMed Web of Science ®Google Scholar
• Othman BA, Greenwood C, Abuelela AF, et al. Targeted cancer therapy: correlative light-electron microscopy shows RGD-targeted ZnO nanoparticles dissolve in the intracellular environment of triple negative breast cancer cells and cause apoptosis with intratumor heterogeneity (Adv. Healthcare Mater. 11/2016). Adv Healthc Mater. 2016;5(11):1248. doi:10.1002/adhm.20167005327275627
   PubMedGoogle Scholar
• Chen N, Hanly L, Rieder M, Yeger H, Koren G. The effect of N-acetylcysteine on the antitumor activity of ifosfamide. Can J Physiol Pharmacol. 2011;89(5):335–343. doi:10.1139/y11-02821609276
   PubMedGoogle Scholar
• Hanly L, Figueredo R, Rieder M, Koropatnick J, Koren G. The effects of N-acetylcysteine on ifosfamide efficacy in a mouse xenograft model. Anticancer Res. 2012;32(9):3791–3798.22993321
   PubMed Web of Science ®Google Scholar
• Vimala K, Sundarraj S, Paulpandi M, Vengatesan S, Kannan S. Green synthesized doxorubicin loaded zinc oxide nanoparticles regulates the Bax and Bcl-2 expression in breast and colon carcinoma. Process Biochem. 2014;49(1):160–172. doi:10.1016/j.procbio.2013.10.007
   Web of Science ®Google Scholar
• Adamcakova-Dodd A, Stebounova LV, Kim JS, et al. Toxicity assessment of zinc oxide nanoparticles using sub-acute and sub-chronic murine inhalation models. Part Fibre Toxicol. 2014;11(1):15. doi:10.1186/1743-8977-11-1524684892
   PubMed Web of Science ®Google Scholar
• Esmaeillou M, Moharamnejad M, Hsankhani R, Tehrani AA, Maadi H. Toxicity of ZnO nanoparticles in healthy adult mice. Environ Toxicol Pharmacol. 2013;35(1):67–71. doi:10.1016/j.etap.2012.11.00323262039
   PubMed Web of Science ®Google Scholar
• Chen N, Aleksa K, Woodland C, Rieder M, Koren G. N-Acetylcysteine prevents ifosfamide-induced nephrotoxicity in rats. Br J Pharmacol. 2008;153(7):1364–1372. doi:10.1038/bjp.2008.1518278066
   PubMedGoogle Scholar
• Pati R, Das I, Mehta RK, Sahu R, Sonawane A. Zinc-oxide nanoparticles exhibit genotoxic, clastogenic, cytotoxic and actin depolymerization effects by inducing oxidative stress responses in macrophages and adult mice. Toxicol Sci. 2016;150(2):454–472. doi:10.1093/toxsci/kfw01026794139
   PubMed Web of Science ®Google Scholar
• Arora-Kuruganti P, Lucchesi PA, Wurster RD. Proliferation of cultured human astrocytoma cells in response to an oxidant and antioxidant. J Neurooncol. 1999;44(3):213–221.10720201
   PubMed Web of Science ®Google Scholar
• Kurata S-I. Selective activation of p38 MAPK cascade and mitotic arrest caused by low level oxidative stress. J Biol Chem. 2000;275(31):23413–23416. doi:10.1074/jbc.C00030820010856288
   PubMedGoogle Scholar
• Liu M, Wikonkal NM, Brash D E. Induction of cyclin-dependent kinase inhibitors and G(1) prolongation by the chemopreventive agent N-acetylcysteine. Carcinogenesis. 1999;20(9):1869–1872.10469636
   PubMed Web of Science ®Google Scholar
• Havre PA, O’Reilly S, McCormick JJ, Brash D E. Transformed and tumor-derived human cells exhibit preferential sensitivity to the thiol antioxidants, N-acetyl cysteine and penicillamine. Cancer Res. 2002;62(5):1443–1449.11888918
   PubMed Web of Science ®Google Scholar